iVexSol, Inc

iVexSol, Inc., located in Lexington, MA, is dedicated to revolutionizing clinical development by developing transformative vector production technologies specifically for cell and gene therapies. Their Intelligent Manufacturing solutions offer scalable, cost-effective, and time-saving options that support every stage of clinical programs, from preclinical phases to product launch.

Through innovative processes such as their next-generation plasmid-free lentiviral vector production platform, iVexSol addresses common challenges faced in vector supply, ensuring rapid and reliable access to high-quality vectors on demand. With a focus on enhancing patient access to advanced therapies like CAR-T, iVexSol aims to eliminate the limitations posed by traditional production methods, ultimately improving timelines and reducing costs in clinical development.

Generated from the website